DENTSPLY SIRONA (XRAY) Expected to Announce Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) is projected to announce its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.47 per share and revenue of $920.26 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

DENTSPLY SIRONA Stock Up 1.6 %

Shares of NASDAQ:XRAY opened at $19.05 on Tuesday. The stock has a market cap of $3.79 billion, a price-to-earnings ratio of -9.20, a PEG ratio of 1.80 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $34.91. The business’s 50 day moving average is $18.91 and its 200 day moving average is $21.64.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a dividend of $0.16 per share. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.36%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Analysts Set New Price Targets

Several research analysts recently issued reports on XRAY shares. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their target price for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Needham & Company LLC reissued a “buy” rating and issued a $25.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Morgan Stanley cut their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. Finally, Mizuho started coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price objective on the stock. Ten research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $25.85.

Get Our Latest Stock Report on XRAY

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.